Solutions for your biologics & peptide optimization and manufacturing needs.
Case Study
We screened a 2,000-member variant library for the expression of 2 different nanobodies. We identified strains with 3-6 g/L production titers in a single round of screening.
Unique genetic designs tested
Improvement in methanol-free expression over previous best-in-class
Observed recombinant protein product titer
Scale of fermentation validated
Ginkgo's achievement of the first milestone has both excited and inspired us, giving us the confidence to move into the next phase of this ambitious project. This progress is a strong indicator of the potential we have to engineer biological systems that will expand the chemical space of biological medicines.
- Novo Nordisk
